-
341
-
342
Circadian Genes Expression Patterns in Disorders Due to Enzyme Deficiencies in the Heme Biosynthetic Pathway
Published 2022-12-01“…Enzyme deficiencies in the heme biosynthetic pathway provoke rare human inherited metabolic diseases called porphyrias. Protein levels and activity of enzymes involved in the heme biosynthetic pathway and especially 5′-Aminolevulinate Synthase 1 are featured by 24-h rhythmic oscillations driven by the biological clock. …”
Get full text
Article -
343
Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis
Published 2018-09-01“…This approach has not been widely used to explore inherited metabolic diseases. This study investigates mucopolysaccharidosis type III (MPS III). …”
Get full text
Article -
344
-
345
Instrumented assessment of gait disturbance in PMM2-CDG adults: a feasibility analysis
Published 2024-02-01Get full text
Article -
346
The complete European guidelines on phenylketonuria: diagnosis and treatment
Published 2017-10-01Get full text
Article -
347
-
348
Patients’ view on gene therapy development for lysosomal storage disorders: a qualitative study
Published 2022-10-01Get full text
Article -
349
Metabolic autopsy with next generation sequencing in sudden unexpected death in infancy: Postmortem diagnosis of fatty acid oxidation disorders
Published 2015-12-01“…The recent introduction of metabolic autopsy in the field of forensic science has made it possible to detect hidden inherited metabolic diseases. Since the next generation sequencing (NGS) has recently become available for use in postmortem examinations, we used NGS to perform metabolic autopsy in 15 sudden unexpected death in infancy cases. …”
Get full text
Article -
350
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases.
Published 2020-01-01“…INTRODUCTION:Lysosomal storage diseases (LSDs) are rare inherited metabolic diseases characterized by an abnormal accumulation of various toxic materials in the cells as a result of enzyme deficiencies leading to tissue and organ damage. …”
Get full text
Article -
351
Diagnostic challenges and outcome of fatty acid oxidation defects in a tertiary care center in Lebanon
Published 2024-08-01Get full text
Article -
352
Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)
Published 2020-11-01“…Abstract Background Mucopolysaccharidoses (MPSs) are a group of inherited metabolic diseases, which are characterized by the accumulation of glycosaminoglycans, and eventually lead to the progressive damage of various tissues and organs. …”
Get full text
Article -
353
-
354
-
355
Renal Phenotype in Mitochondrial Diseases: A Multicenter Study
Published 2022-01-01Get full text
Article -
356
A novel mutation in GTPBP3 causes combined oxidative phosphorylation deficiency 23 by affecting pre-mRNA splicing
Published 2024-03-01“…The metabolic profiles of amino acids in blood, acylcarnitine in blood and organic acids in urine were used to determine the presence of inherited metabolic diseases. Genetic variations in the family were investigated using whole-exome sequencing and Sanger sequencing. …”
Get full text
Article -
357
-
358
-
359
Outcomes of mitochondrial long chain fatty acid oxidation and carnitine defects from a single center metabolic genetics clinic
Published 2022-09-01“…Abstract Background Mitochondrial long-chain fatty acid oxidation and carnitine metabolism defects are a group of inherited metabolic diseases. We performed a retrospective cohort study to report on the phenotypic and genotypic spectrum of mitochondrial long-chain fatty acid oxidation and carnitine metabolism defects as well as their treatment outcomes. …”
Get full text
Article -
360
Better understanding the phenotypic effects of drugs through shared targets in genetic disease networks
Published 2025-01-01Get full text
Article